Osteoporosis drug shows potential against diseases caused by excess iron, finds study Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTResearchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat...
Effectiveness of exercise to ease osteoarthritis symptoms likely minimal and transient, suggests study Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTThe effectiveness of exercise therapy to ease the symptoms of osteoarthritis is likely minimal, short lived, and probably no better than no treatment...
Women Prefer In-Clinic Cervical Cancer Screening to in-home screening; Evidence Supports Longer Screening Intervals Dr Riya Dave24 Feb 2026 8:30 PM ISTTwo recent analyses highlight evolving perspectives on cervical cancer (CC) screening. One study from the United States found that a majority of women...
Cardiometabolic Risk Factors: Indian Study Highlights Rising Prevalence Aashi verma24 Feb 2026 8:30 PM ISTA recent study in India reveals a high cardiometabolic burden, especially in urban areas, with prevalence rates of 44% for hypertension, 21% for...
Hemorrhagic Gastric Diverticulum Mimics Adrenal Tumor: A Case Report Dr Riya Dave24 Feb 2026 8:00 PM ISTA case report published in BMC Surgery by Jia Li. and colleagues has shown that a hemorrhagic gastric diverticulum can very much resemble a left...
Dapagliflozin May Reduce Liver Fat in Type 2 Diabetes Independent of Weight Loss: Study Dr Riya Dave24 Feb 2026 9:30 AM ISTResearchers have found in a secondary analysis of a clinical trial published in Obesity that taking dapagliflozin 10 mg daily for 12 months was...
Low- and High-Dose Vitamin D Show Similar Outcomes in Nutritional Rickets: Study Dr. Shravani Dali24 Feb 2026 9:15 AM ISTResearchers have found in a new study that there was no statistically significant or clinically meaningful differences were observed between children...
CagriSema Fails to Demonstrate Noninferiority to Tirzepatide for Weight Loss: Phase 3 REDEFINE Trial Dr. Kamal Kant Kohli24 Feb 2026 9:15 AM ISTTopline results from a phase 3 clinical trial compared CagriSema with tirzepatide in patients with obesity. CagriSema is a fixed-dose combination of...
Ticagrelor Not Noninferior to Prasugrel After PCI in Diabetes: JAMA Dr Riya Dave23 Feb 2026 9:00 PM ISTIn a recent study, ticagrelor was found to be noninferior to prasugrel for a composite of ischemic events including death, myocardial infarction,...
Angiotensin II-Stimulating vs Inhibiting BP Drugs: Stimulating Class Linked to Lower Dementia Pathology Risk, JAMA Medha Baranwal23 Feb 2026 9:00 PM ISTUSA: Researchers have discovered in a new research that compared with angiotensin II-inhibiting antihypertensives, angiotensin II-stimulating...
Investigational TSND-201 Shows Early and Significant Efficacy in Severe PTSD in Phase II Trial Medha Baranwal23 Feb 2026 8:45 PM ISTUSA: The investigational neuroplastogen TSND-201 demonstrated significant efficacy in patients with severe post-traumatic stress disorder (PTSD) in a...
Bimekizumab Sustains QoL Gains to 3 Years in Psoriasis: JAMA Dr Riya Dave23 Feb 2026 8:45 PM ISTAccording to a new study published in JAMA Dermatology by Matthias A. and colleagues bimekizumab led to rapid and sustained improvements in symptoms...
